Chinese Guideline on the Primary Prevention of Cardiovascular Diseases

被引：29

作者：

Liu, Jing ^{[1
,5
]}

Sun, Yihong ^{[2
]}

Peng, Daoquan ^{[3
]}

Zhang, Yuqing ^{[4
]}

Gao, Runlin ^{[4
]}

Zhao, Dong ^{[1
]}

Wang, Ji-Guang ^{[6
]}

Ye, Ping ^{[7
,46
]}

Guo, Yifang ^{[8
]}

Yang, Xinchun ^{[9
,45
]}

Chen, Luyuan ^{[10
]}

Li, Jianjun ^{[4
]}

Cheng, Xiang ^{[11
]}

Bian, Huiping ^{[12
]}

Cai, Jun ^{[4
]}

Chen, Guiying ^{[13
]}

Chen, Hong ^{[5
]}

Chen, Jiyan ^{[10
]}

Chen, Xiaoping ^{[2
]}

Chen, Zhenyue ^{[14
]}

Chen, Luyuan ^{[10
]}

Dai, Ruozhu ^{[15
]}

Ding, Rongjing ^{[5
]}

Ding, Shifang ^{[16
]}

Dong, Xugang ^{[17
]}

Fan, Zhiqing ^{[18
]}

Feng, Yingqing ^{[10
]}

Fu, Xianghua ^{[19
]}

Gao, Runlin ^{[4
]}

Guo, Jianjun ^{[20
]}

Han, Yaling ^{[21
]}

Hou, Jingbo ^{[22
]}

Hu, Dayi ^{[5
]}

Huang, Kai ^{[11
,23
]}

Ji, Linong ^{[5
]}

Jia, Shaobin ^{[24
]}

Jiang, Hong ^{[25
]}

Jing, Zhi-Cheng ^{[26
]}

Li, Liwen ^{[10
]}

Li, Chunjian ^{[27
]}

Li, Jianjun ^{[4
]}

Li, Ling ^{[28
]}

Li, Xiaodong ^{[29
]}

Li, Xinli ^{[30
]}

Li, Yi ^{[21
]}

Li, Yuming ^{[31
]}

Liang, Chun ^{[32
]}

Liu, Jing ^{[1
,5
]}

Liu, Peiliang ^{[33
]}

Ma, Changsheng ^{[1
]}

机构：

[1] Capital Med Univ, Beijing Anzhen Hosp, Beijing, Peoples R China

[2] China Japan Friendship Hosp, Beijing, Peoples R China

[3] Cent South Univ, Xiangya Hosp 2, Changsha, Peoples R China

[4] Chinese Acad Med Sci, Fuwai Hosp, Beijing, Peoples R China

[5] Peking Univ Peoples Hosp, Beijing, Peoples R China

[6] Shanghai Jiao Tong Univ, Ruijin Hosp, Shanghai Inst Hypertens, Sch Med, Shanghai, Peoples R China

[7] Gen Hosp Chinese Peoples Liberat Army, Med Ctr 2, Nanjing, Peoples R China

[8] Hebei Gen Hosp, Shijiazhuang, Hebei, Peoples R China

[9] Capital Med Univ, Beijing Chaoyang Hosp, Beijing, Peoples R China

[10] Guangdong Gen Hosp, Guangzhou, Peoples R China

[11] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Wuhan, Peoples R China

[12] Qinghai Prov Cardiovasc & Cerebrovasc Dis Special, Xining, Peoples R China

[13] Harbin Med Univ, Affiliated Hosp 1, Harbin, Peoples R China

[14] Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med, Shanghai, Peoples R China

[15] Fujian Med Univ, Quanzhou Hosp 1, Fuzhou, Peoples R China

[16] Gen Hosp Cent Theatre Command, Nanjing, Peoples R China

[17] Sun Yat Sen Univ, Affiliated Hosp 1, Guangzhou, Peoples R China

[18] Daqing Oilfields Gen Hosp, Daqing, Peoples R China

[19] Hebei Med Univ, Hosp 2, Shijiazhuang, Hebei, Peoples R China

[20] Capital Inst Phys Educ, Beijing, Peoples R China

[21] Gen Hosp Northern Theater Command, Shenyang, Peoples R China

[22] Harbin Med Univ, Affiliated Hosp 2, Harbin, Peoples R China

[23] Huazhong Univ Sci & Technol, Tongji Med Coll, Liyuan Cardiovasc Clin Ctr, Wuhan, Peoples R China

[24] Gen Hosp Ningxia Med Univ, Yinchuan, Ningxia, Peoples R China

[25] Peoples Hosp Wuhan Univ, Wuhan, Peoples R China

[26] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Beijing, Peoples R China

[27] Jiangsu Prov Hosp, Nanjing, Peoples R China

[28] Zhengzhou Univ, Affiliated Hosp 1, Zhengzhou, Peoples R China

[29] China Med Univ, Shengjing Hosp, Shenyang, Peoples R China

[30] Nanjing Med Univ, Affiliated Hosp 1, Nanjing, Peoples R China

[31] Teda Int Cardiovasc Hosp, Tianjin, Peoples R China

[32] Shanghai Changzheng Hosp, Shanghai, Peoples R China

[33] Liaoning Jinqiu Hosp, Shenyang, Peoples R China

[34] Affiliated Hosp Changchun Univ Chinese Med, Changchun, Peoples R China

[35] Peking Univ, Hlth Sci Ctr, Meinian Inst Publ Hlth, Beijing, Peoples R China

[36] Dalian Med Univ, Affiliated Hosp 2, Dalian, Peoples R China

[37] Tongji Univ, Tongji Hosp, Shanghai, Peoples R China

[38] Capital Med Univ, Beijing Tongren Hosp, Beijing, Peoples R China

[39] Peking Univ Third Hosp, Beijing, Peoples R China

[40] Zhengzhou Cent Hosp, Zhengzhou, Peoples R China

[41] Peoples Liberat Army Strateg Support Force Charac, Beijing, Peoples R China

[42] China Japan Friendship Hosp, Natl Resp Med Ctr, Tobacco Med & Tobacco Cessat Ctr, Beijing, Peoples R China

[43] Affiliated Hosp Nanjing Univ, Nanjing Drum Tower Hosp, Med Sch, Nanjing, Peoples R China

[44] 920 Hosp Joint Logist Support Force Chinese Peopl, Kunming, Yunnan, Peoples R China

[45] Capital Med Univ, Beijing Chaoyang Hosp, Beijing, Peoples R China

[46] Chinese Peoples Liberat Army Gen Hosp, Med Ctr 2, Nanjing, Peoples R China

[47] Fudan Univ, Sch Publ Hlth, Shanghai, Peoples R China

[48] Xi An Jiao Tong Univ, Affiliated Hosp 1, Xian, Peoples R China

[49] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Wuhan, Peoples R China

[50] Nanjing First Hosp, Nanjing, Peoples R China

来源：

CARDIOLOGY DISCOVERY | 2021年 / 1卷 / 02期

关键词：

Cardiovascular disease; Primary prevention; Guideline; CORONARY-HEART-DISEASE; DENSITY-LIPOPROTEIN CHOLESTEROL; TYPE-2; DIABETES-MELLITUS; PRESSURE-LOWERING TREATMENT; ALL-CAUSE MORTALITY; INDIVIDUAL-PARTICIPANT DATA; INTIMA-MEDIA THICKNESS; TRIGLYCERIDE-RICH LIPOPROTEINS; ACUTE MYOCARDIAL-INFARCTION; GLOMERULAR-FILTRATION-RATE;

D O I：

10.1097/CD9.0000000000000025

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Cardiovascular disease is the leading cause of mortality in China. Primary prevention of cardiovascular disease with a focus on lifestyle intervention and risk factor control has been shown to effectively delay or prevent the occurrence of cardiovascular events. To promote a healthy lifestyle and enhance the detection, diagnosis, and treatment of cardiovascular risk factors such as hypertension, dyslipidemia, and diabetes, and to improve the overall capacity of primary prevention of cardiovascular disease, the Chinese Society of Cardiology of Chinese Medical Association has collaborated with multiple societies to summarize and evaluate the latest evidence with reference to relevant guidelines and subsequently to develop recommendations for primary cardiovascular disease prevention in Chinese adults. The guideline consists of 10 sections: introduction, methodology for developing the guideline, epidemiology of cardiovascular disease in China and challenges in primary prevention, general recommendations for primary prevention, assessment of cardiovascular risk, lifestyle intervention, blood pressure control, lipid management, management of type 2 diabetes, and use of aspirin. The promulgation and implementation of this guideline will play a key role in promoting the practice of primary prevention for cardiovascular disease in China.

引用

页码：70 / 104

页数：35

共 402 条

[1]

[Anonymous], 2019, Annual report, P8

[2] A clinical trial of the effects of dietary patterns on blood pressure [J].

Appel, LJ ;

Moore, TJ ;

Obarzanek, E ;

Vollmer, WM ;

Svetkey, LP ;

Sacks, FM ;

Bray, GA ;

Vogt, TM ;

Cutler, JA ;

Windhauser, MM ;

Lin, PH ;

Karanja, N .

NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (16) :1117-1124

[3]

Arnett DK, 2019, CIRCULATION, V140, pE563, DOI [10.1016/j.jacc.2019.03.009, 10.1161/CIR.0000000000000677, 10.1161/CIR.0000000000000678, 10.1016/j.jacc.2019.03.010]

[4] Obesity is associated with incident atrial fibrillation independent of gender: A meta-analysis [J].

Asad, Zain ;

Abbas, Mubasher ;

Javed, Isma ;

Korantzopoulos, Panagiotis ;

Stavrakis, Stavros .

JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2018, 29 (05) :725-732

[5] Effects of the Dietary Approaches to Stop Hypertension (DASH) Eating Plan on Cardiovascular Risks Among Type 2 Diabetic Patients A randomized crossover clinical trial [J].

Azadbakht, Leila ;

Fard, Nafiseh Rashidi Pour ;

Karimi, Majid ;

Baghaei, Mohammad Hassan ;

Surkan, Pamela J. ;

Rahimi, Majid ;

Esmaillzadeh, Ahmad ;

Willett, Walter C. .

DIABETES CARE, 2011, 34 (01) :55-57

[6] Adherence to a healthy lifestyle and a DASH-style diet and risk of hypertension in Chinese individuals [J].

Bai, Guoyin ;

Zhang, Ji ;

Zhao, Chongsi ;

Wang, Yan ;

Qi, Yanmin ;

Zhang, Bing .

HYPERTENSION RESEARCH, 2017, 40 (02) :196-202

[7] Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials [J].

Baigent, C. ;

Blackwell, L. ;

Emberson, J. ;

Holland, L. E. ;

Reith, C. ;

Bhala, N. ;

Peto, R. ;

Barnes, E. H. ;

Keech, A. ;

Simes, J. ;

Collins, R. .

LANCET, 2010, 376 (9753) :1670-1681

[8] Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins [J].

Baigent, C ;

Keech, A ;

Kearney, PM ;

Blackwell, L ;

Buck, G ;

Pollicino, C ;

Kirby, A ;

Sourjina, T ;

Peto, R ;

Collins, R ;

Simes, J .

LANCET, 2005, 366 (9493) :1267-1278

[9] The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial [J].

Baigent, Colin ;

Landray, Martin J. ;

Reith, Christina ;

Emberson, Jonathan ;

Wheeler, David C. ;

Tomson, Charles ;

Wanner, Christoph ;

Krane, Vera ;

Cass, Alan ;

Craig, Jonathan ;

Neal, Bruce ;

Jiang, Lixin ;

Hooi, Lai Seong ;

Levin, Adeera ;

Agodoa, Lawrence ;

Gaziano, Mike ;

Kasiske, Bertram ;

Walker, Robert ;

Massy, Ziad A. ;

Feldt-Rasmussen, Bo ;

Krairittichai, Udom ;

Ophascharoensuk, Vuddidhej ;

Fellstrom, Bengt ;

Holdaas, Hallvard ;

Tesar, Vladimir ;

Wiecek, Andrzej ;

Grobbee, Diederick ;

de Zeeuw, Dick ;

Gronhagen-Riska, Carola ;

Dasgupta, Tanaji ;

Lewis, David ;

Herrington, William ;

Mafham, Marion ;

Majoni, William ;

Wallendszus, Karl ;

Grimm, Richard ;

Pedersen, Terje ;

Tobert, Jonathan ;

Armitage, Jane ;

Baxter, Alex ;

Bray, Christopher ;

Chen, Yiping ;

Chen, Zhengming ;

Hill, Michael ;

Knott, Carol ;

Parish, Sarah ;

Simpson, David ;

Sleight, Peter ;

Young, Alan ;

Collins, Rory .

LANCET, 2011, 377 (9784) :2181-2192

[10] Association of Nut Consumption with Total and Cause-Specific Mortality [J].

Bao, Ying ;

Han, Jiali ;

Hu, Frank B. ;

Giovannucci, Edward L. ;

Stampfer, Meir J. ;

Willett, Walter C. ;

Fuchs, Charles S. .

NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (21) :2001-2011

← 1 2 3 4 5 6 7 8 9 10 →